✕
Login
Register
Back to News
Morgan Stanley Maintains Equal-Weight on Exelixis, Raises Price Target to $50
Benzinga Newsdesk
www.benzinga.com
Positive 87.2%
Neg 0%
Neu 0%
Pos 87.2%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment